I agree. When I first posted the French paper on HC I didn't expect RAC to go after T2D with their own pre-clinical. My thinking is that anything beyond cancer will be outside RAC's circle of competence and too much of a distraction to pursue outright...
HOWEVER that doesn't eliminate the possibility of minor adaptions to existing programs. Any chances here @RaceOncology?
- Forums
- ASX - By Stock
- RAC
- Ann: Quarterly Activity Report & Appendix 4C
Ann: Quarterly Activity Report & Appendix 4C, page-26
-
-
- There are more pages in this discussion • 51 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAC (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.80 |
Change
0.085(4.97%) |
Mkt cap ! $311.6M |
Open | High | Low | Value | Volume |
$1.85 | $1.96 | $1.75 | $710.1K | 383.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 14815 | $1.77 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.80 | 3500 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 14154 | 1.770 |
1 | 18 | 1.765 |
1 | 5698 | 1.755 |
2 | 4141 | 1.750 |
2 | 800 | 1.740 |
Price($) | Vol. | No. |
---|---|---|
1.785 | 1200 | 1 |
1.790 | 3000 | 1 |
1.795 | 1570 | 1 |
1.810 | 3575 | 2 |
1.820 | 480 | 1 |
Last trade - 13.06pm 26/06/2024 (20 minute delay) ? |
Featured News
RAC (ASX) Chart |